Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female COPD patients aged ≥ 40 years~* Current smokers or ex-smokers~* FEV1\<50% predicted (FEV1/FVC \<0,7)~* at least 1 documented exacerbations in the last 12 Mo~Exclusion Criteria:~* Pregnant or lactating women and all women physiologically capable of becoming pregnant~* Diagnosis of asthma, history of allergic rhinitis or atopy~* Patients treated for exacerbations 1 Mo prior to screening~* Patients treated with non-cardioselective β-blockers~* Patients treated with long-acting antihistamines~* Known respiratory disorders other than COPD~* Patients who have clinically significant cardiovascular condition

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BDP/FF/GB (Type: EXPERIMENTAL): CHF 5993 pMDI 100/6/12.5 mcg 2 inhalations b.i.d
- Tiotropium (Type: ACTIVE_COMPARATOR): Tiotropium bromide 18 mcg
- BDP/FF + Tiotropium (Type: ACTIVE_COMPARATOR): BDP/FF pMDI 100/6/12.5 mcg 2 inhalations b.i.d and Tiotropium 18 mcg daily~BDP/FF/GB versus BDP/FF + Tiotropium

Based on this trial design, predict the completion outcome and termination type (if applicable).